During the past decade, Ospedale Evangelico Valdese conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Evangelico Valdese" are "Atrial Fibrillation" (1 trials), "Breast Cancer" (1 trials), "Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Ospedale Evangelico Valdese" in a lesser frequency.

Most popular intervention types in "Ospedale Evangelico Valdese" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rosuvastatin" (1 trials), "Valsartan" (1 trials), "cyclophosphamide" (1 trials) and "epirubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Evangelico Valdese" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Evangelico Valdese". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ospedale Evangelico Valdese, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Evangelico Valdese, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".